Dis-chem revenue rose 9.4% to R17.9 billion in the 6 months to end August.

Loading player...
GUEST - GUEST - Rui Morais – Dis-Chem CEO

Pharmacy group Dis-Chem is growing revenue, profits are under pressure as it fights for market share in a tough economy. Group revenue rose 9.4% to R17.9 billion in the six months to end August, the group announced on Friday, or just over 10% when excluding the effect of Covid-19 vaccines in the prior period. But headline earnings fell about 17% to just under R500 million, with margins under pressure in personal care and beauty as the retailer picked up its promotional activity.
6 Nov 2023 3PM English South Africa Business News · Investing

Other recent episodes

Bitcoin at the Fed’s Crossroads

Bitcoin briefly touched a 12‑week high before pulling back—but with spot ETFs seeing some of their strongest inflows of the cycle, the market is shifting fast. Rob Price, CIO of Sound Money Capital, explains whether Bitcoin is still trading like a high‑beta macro asset or evolving into true sound money.
27 Apr 1PM 17 min

Oil’s Hidden Risks & Gold’s War Paradox

Oil is stuck near $90–95, but portfolio manager John Hasslet says the market is being held up by physical bottlenecks, not real fundamentals. He also unpacks why gold is falling during a major war and how inflation expectations are overpowering safe‑haven demand.
27 Apr 1PM 13 min

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min